Position in ABBV
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,056,348
-$120,375 QoQ
Shares Held
4,857
-5.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CYBER HORNET ETFs LLC holds $7,351,674 across 9 Drug Manufacturers - General names. ABBV ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,183 | $2,007,857 | |
| 2 | JNJ |
Johnson & Johnson
|
6,623 | $1,618,926 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,857 | $1,056,348 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,823 | $820,738 | |
| 5 | AMGN |
Amgen Inc
|
1,479 | $520,386 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,410 | $475,251 | |
| 7 | PFE |
Pfizer Inc
|
15,630 | $438,890 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,596 | $339,397 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,056,348 | 4,857 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,176,723 | 5,150 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,136,629 | 4,909 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $877,054 | 4,725 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $1,000,248 | 4,774 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $847,095 | 4,767 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $915,714 | 4,637 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $792,250 | 4,619 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $833,653 | 4,578 | Shares | Sole | 2024-11-13 | |
| 2023-12-31 | $723,399 | 4,668 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||